Interventional Cardiology Devices | Market Insights | Japan | 2024
The Japanese IC device market is driven by an expanding CAD patient pool, the growing prevalence of complex lesions, improving access to treatment, the emerging preference for minimally invasive procedures for treating CAD cases, and the emergence of technologically advanced premium-priced diagnostic and treatment devices providing case-specific diagnosis and intervention for CAD cases with different levels of complexity. However, market revenues will be offset by eroding ASPs due to biennial reimbursement cuts by the MHLW, particularly in the mature PTCA balloon catheter and coronary stent segments, resulting in overall market contraction over the forecast period.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for IC devices in Japan from 2019 through 2032.
